Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to participate voluntarily, sign a consent form, and are able to follow the study requirements
- People aged between 18 and 75 years old, who are reasonably physically active (able to carry out daily activities with some limitations at most), and who are expected to survive for at least 12 weeks
- People who have been diagnosed with multiple myeloma based on internationally recognised diagnostic standards, with medical records confirming this
- People whose cancer can be measured through tests or scans
- People whose major organs (such as the heart, liver, and kidneys) are functioning normally
- People who are willing and able to use effective contraception during the study
Who may not be able to join:
- People who have taken certain approved Chinese herbal or patent medicines listed as having anti-tumour properties within 2 weeks before the trial starts
- People who have received targeted therapy or immunotherapy within 3 weeks before the trial starts
- People who have a known allergy to any of the study medications, similar medicines, or their ingredients
- People who have had another type of cancer at any point in the past 3 years before joining the trial
- People who still have unresolved side effects from a previous treatment that are rated above a mild level (confirm with trial site)
- People who have had major surgery or a significant injury within 4 weeks before the trial starts, or who are expected to need major surgery during the study period
- People who have experienced a blood clot in an artery or vein within the 6 months before the trial starts
- People with a history of substance abuse involving psychotropic drugs that has not been resolved, or people with a diagnosed mental health disorder
- People with any severe or uncontrolled medical condition
- People whose overall health, in the opinion of the trial doctors, could put them at serious risk or prevent them from completing the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 028-85423046
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose Limiting Toxicities (DLT); Maximum tolerated dose (MTD); Recommended Phase II Dose (RP2D); Number of patients with adverse events (AEs) and serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.